Evaluation of Hepatitis A Seroprevalance and Epidemiologic Data of Patients Applying to A Medical Faculty Hospital

Basit Öğe Kaydı
dc.authoridCELIK, CEM/0000-0002-7141-5874
dc.authoridhasbek, mursit/0000-0002-5217-8607
dc.authoridSAGLAM, Murat/0000-0002-1215-1063
dc.contributor.authorSaglam, Murat
dc.contributor.authorCelik, Cem
dc.contributor.authorKafa, Ayse Humeyra Taskin
dc.contributor.authorHasbek, Mursit
dc.date.accessioned2024-10-26T18:00:09Z
dc.date.available2024-10-26T18:00:09Z
dc.date.issued2020
dc.departmentSivas Cumhuriyet Üniversitesi
dc.description.abstractObjectives: Our study aims to determine seroprevalence of hepatitis A virus (HAV) in our region and to determine the prevalence change over years and to evaluate the effects of various factors on prevalence. Materials and Methods: In our study, HAV diagnostic tests, which were studied by the ELISA method in the microbiology laboratory of our hospital for 10 years, were evaluated retrospectively from the laboratory information system. In the diagnosis of acute hepatitis, and anti-HAV immunoglobulin M (IgM) antibody was investigated in the blood, and anti-HAV IgG antibody was investigated for immunity to hepatitis A. Results: Seropositivity of anti-HAV IgG was found to be 75.3%, In comparison, while anti-HAV IgM positivity was found to be 2.7%. While anti-HAV IgG and anti-HAV IgM positivity were found to be higher in individuals living outside the city center compared to individuals living in the city center, no significant difference was found between the genders. Conclusion: Virus transmission has decreased in our region in recent years, and the encounter with the disease has shifted to advanced ages. This change increases the number of individuals susceptible to symptomatic infection. Therefore, hygiene and sanitation conditions should be monitored carefully, infrastructure should work adequately, and vaccination policies should be implemented when necessary.
dc.identifier.doi10.4274/vhd.galenos.2020.2019.0037
dc.identifier.endpage109
dc.identifier.issn1307-9441
dc.identifier.issn2147-2939
dc.identifier.issue2
dc.identifier.startpage104
dc.identifier.trdizinid376493
dc.identifier.urihttps://doi.org/10.4274/vhd.galenos.2020.2019.0037
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/376493
dc.identifier.urihttps://hdl.handle.net/20.500.12418/27554
dc.identifier.volume26
dc.identifier.wosWOS:000573999000012
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakTR-Dizin
dc.language.isoen
dc.publisherGalenos Yayincilik
dc.relation.ispartofViral Hepatit Dergisi-Viral Hepatitis Journal
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectHAV seroprevalence
dc.subjectanti-HAV IgG
dc.subjectanti-HAV IgM
dc.titleEvaluation of Hepatitis A Seroprevalance and Epidemiologic Data of Patients Applying to A Medical Faculty Hospital
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu